{"id":69555,"date":"2026-04-10T13:33:07","date_gmt":"2026-04-10T08:03:07","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=69555"},"modified":"2026-04-10T13:33:09","modified_gmt":"2026-04-10T08:03:09","slug":"tatva-chintan-surges-22-in-1-month-is-this-green-chemistry-ipo-gem-finally-making-good-on-its-promise","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/tatva-chintan-surges-22-in-1-month-is-this-green-chemistry-ipo-gem-finally-making-good-on-its-promise\/","title":{"rendered":"Tatva Chintan Surges 22% in 1 Month \u2014 Is This Green Chemistry IPO Gem Finally Making Good on Its Promise?"},"content":{"rendered":"<p>Tatva Chintan Pharma Chem has surged 22% in one month \u2014 and for investors who bought into the IPO buzz of 2021 and watched the stock collapse 50%+ from its listing price, this recovery is both exciting and overdue.<\/p><p>This article covers every key reason behind Tatva Chintan Pharma&#8217;s recent surge, what the data says about sustainability, the short-term and long-term share price targets for 2026, and what catalysts and risks investors need to monitor before making any decision.<\/p><p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Click Here 2013 Get Free Investment Predictions on Univest<\/strong><\/a>.<\/p><div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/tatva-chintan-surges-22-in-1-month-is-this-green-chemistry-ipo-gem-finally-making-good-on-its-promise\/#About_Tatva_Chintan_Pharma_NSE_TATVA\" title=\"About Tatva Chintan Pharma (NSE: TATVA)\">About Tatva Chintan Pharma (NSE: TATVA)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/tatva-chintan-surges-22-in-1-month-is-this-green-chemistry-ipo-gem-finally-making-good-on-its-promise\/#Why_Is_Tatva_Chintan_Pharma_Share_Price_Rising_The_Surge_Explained\" title=\"Why Is Tatva Chintan Pharma Share Price Rising? The Surge Explained\">Why Is Tatva Chintan Pharma Share Price Rising? The Surge Explained<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/tatva-chintan-surges-22-in-1-month-is-this-green-chemistry-ipo-gem-finally-making-good-on-its-promise\/#Financial_Performance_%E2%80%94_What_the_Numbers_Say\" title=\"Financial Performance \u2014 What the Numbers Say\">Financial Performance \u2014 What the Numbers Say<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/tatva-chintan-surges-22-in-1-month-is-this-green-chemistry-ipo-gem-finally-making-good-on-its-promise\/#Key_Catalysts_That_Could_Drive_Tatva_Chintan_Pharma_Share_Price_Higher\" title=\"Key Catalysts That Could Drive Tatva Chintan Pharma Share Price Higher\">Key Catalysts That Could Drive Tatva Chintan Pharma Share Price Higher<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/tatva-chintan-surges-22-in-1-month-is-this-green-chemistry-ipo-gem-finally-making-good-on-its-promise\/#Risks_to_Watch_Before_Chasing_the_Rally\" title=\"Risks to Watch Before Chasing the Rally\">Risks to Watch Before Chasing the Rally<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/tatva-chintan-surges-22-in-1-month-is-this-green-chemistry-ipo-gem-finally-making-good-on-its-promise\/#Technical_Setup_%E2%80%94_Is_the_Rally_Sustainable\" title=\"Technical Setup \u2014 Is the Rally Sustainable?\">Technical Setup \u2014 Is the Rally Sustainable?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/tatva-chintan-surges-22-in-1-month-is-this-green-chemistry-ipo-gem-finally-making-good-on-its-promise\/#Institutional_Positioning_and_Market_Sentiment\" title=\"Institutional Positioning and Market Sentiment\">Institutional Positioning and Market Sentiment<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/tatva-chintan-surges-22-in-1-month-is-this-green-chemistry-ipo-gem-finally-making-good-on-its-promise\/#Future_Outlook_%E2%80%94_Can_Tatva_Chintan_Pharma_Sustain_the_Rally\" title=\"Future Outlook \u2014 Can Tatva Chintan Pharma Sustain the Rally?\">Future Outlook \u2014 Can Tatva Chintan Pharma Sustain the Rally?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/tatva-chintan-surges-22-in-1-month-is-this-green-chemistry-ipo-gem-finally-making-good-on-its-promise\/#Tatva_Chintan_Pharma_Share_Price_Target_2026\" title=\"Tatva Chintan Pharma Share Price Target 2026\">Tatva Chintan Pharma Share Price Target 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/tatva-chintan-surges-22-in-1-month-is-this-green-chemistry-ipo-gem-finally-making-good-on-its-promise\/#Short-Term_Target_3-6_Months\" title=\"Short-Term Target (3-6 Months)\">Short-Term Target (3-6 Months)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/tatva-chintan-surges-22-in-1-month-is-this-green-chemistry-ipo-gem-finally-making-good-on-its-promise\/#12-Month_Analyst_Consensus_Target\" title=\"12-Month Analyst Consensus Target\">12-Month Analyst Consensus Target<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/tatva-chintan-surges-22-in-1-month-is-this-green-chemistry-ipo-gem-finally-making-good-on-its-promise\/#Long-Term_Target_FY27-FY28\" title=\"Long-Term Target (FY27-FY28)\">Long-Term Target (FY27-FY28)<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/tatva-chintan-surges-22-in-1-month-is-this-green-chemistry-ipo-gem-finally-making-good-on-its-promise\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/tatva-chintan-surges-22-in-1-month-is-this-green-chemistry-ipo-gem-finally-making-good-on-its-promise\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/tatva-chintan-surges-22-in-1-month-is-this-green-chemistry-ipo-gem-finally-making-good-on-its-promise\/#Q1_Why_did_Tatva_Chintan_surge_22_in_1_month\" title=\"Q1. Why did Tatva Chintan surge 22% in 1 month?\">Q1. Why did Tatva Chintan surge 22% in 1 month?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/tatva-chintan-surges-22-in-1-month-is-this-green-chemistry-ipo-gem-finally-making-good-on-its-promise\/#Q2_What_is_Tatva_Chintans_share_price_target_2026\" title=\"Q2. What is Tatva Chintan&#8217;s share price target 2026?\">Q2. What is Tatva Chintan&#8217;s share price target 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/tatva-chintan-surges-22-in-1-month-is-this-green-chemistry-ipo-gem-finally-making-good-on-its-promise\/#Q3_What_does_Tatva_Chintan_make\" title=\"Q3. What does Tatva Chintan make?\">Q3. What does Tatva Chintan make?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/tatva-chintan-surges-22-in-1-month-is-this-green-chemistry-ipo-gem-finally-making-good-on-its-promise\/#Q4_What_is_a_Phase_Transfer_Catalyst\" title=\"Q4. What is a Phase Transfer Catalyst?\">Q4. What is a Phase Transfer Catalyst?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/tatva-chintan-surges-22-in-1-month-is-this-green-chemistry-ipo-gem-finally-making-good-on-its-promise\/#Q5_What_is_Tatva_Chintans_market_cap\" title=\"Q5. What is Tatva Chintan&#8217;s market cap?\">Q5. What is Tatva Chintan&#8217;s market cap?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/tatva-chintan-surges-22-in-1-month-is-this-green-chemistry-ipo-gem-finally-making-good-on-its-promise\/#Recent_Article\" title=\"Recent Article\">Recent Article<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"About_Tatva_Chintan_Pharma_NSE_TATVA\"><\/span><strong>About Tatva Chintan Pharma (NSE: TATVA)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>[Click Here \u2013 Get Free Investment Predictions<\/strong><\/a> on Univest.<\/p><p>Tatva Chintan Pharma is a leading company in the Specialty Chemicals space with a market capitalisation of Rs 2,680 Cr. The stock trades at approximately 38x trailing P\/E and has a 52-week range spanning from Rs 980 to Rs 1,850. The current price of Rs 1,240 reflects +22% appreciation 1 month, putting the stock significantly above its recent lows.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Why_Is_Tatva_Chintan_Pharma_Share_Price_Rising_The_Surge_Explained\"><\/span><strong>Why Is Tatva Chintan Pharma Share Price Rising? The Surge Explained<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-image size-large\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"536\" src=\"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/10133100\/image-549-1024x536.jpeg\" alt=\"Tatva Chintan Share Price Target\" class=\"wp-image-69562\" srcset=\"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/10133100\/image-549-1024x536.jpeg 1024w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/10133100\/image-549-300x157.jpeg 300w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/10133100\/image-549-768x402.jpeg 768w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/10133100\/image-549-900x471.jpeg 900w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/10133100\/image-549-600x314.jpeg 600w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/10133100\/image-549-150x79.jpeg 150w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/10133100\/image-549.jpeg 1200w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure><p>Tatva Chintan Pharma share price data \u2014 surge, CMP, 12M target, sector | univest.in<\/p><p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Tap to Access Best Research Pieces on Univest<\/strong><\/a>.<\/p><p>Tatva Chintan&#8217;s Q3 FY26 revenue of Rs 165 crore (+28% YoY) was driven by strong demand for Phase Transfer Catalysts (PTCs) from the agrochemical and pharmaceutical sectors, and initial contributions from the company&#8217;s Structure Directing Agents (SDAs) for zeolite synthesis used in catalytic cracking. PAT of Rs 24 crore (+55% YoY) reflects improved margins as capacity utilisation increases at the new Dahej plant.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Financial_Performance_%E2%80%94_What_the_Numbers_Say\"><\/span><strong>Financial Performance \u2014 What the Numbers Say<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>The underlying financials confirm that the Tatva Chintan Pharma share price surge is not just momentum \u2014 it is backed by improving fundamental performance.<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Metric<\/strong><\/td><td><strong>Latest Quarter<\/strong><\/td><td><strong>Change<\/strong><\/td><td><strong>What It Signals<\/strong><\/td><\/tr><tr><td>Revenue<\/td><td>Rs 165 Cr<\/td><td>+28% YoY<\/td><td>Top-line growth confirmation<\/td><\/tr><tr><td>Net Profit (PAT)<\/td><td>Rs 24 Cr<\/td><td>+55% YoY<\/td><td>Earnings acceleration<\/td><\/tr><tr><td>Market Cap<\/td><td>Rs 2,680 Cr<\/td><td>Current<\/td><td>Valuation context<\/td><\/tr><tr><td>Promoter Holding<\/td><td>47.0%<\/td><td>\u2014<\/td><td>Management confidence<\/td><\/tr><tr><td>FII Holding<\/td><td>8.4%<\/td><td>\u2014<\/td><td>Institutional interest<\/td><\/tr><\/tbody><\/table><\/figure><p>For live Tatva Chintan Pharma fundamental data and peer comparison, check the <a href=\"https:\/\/univest.in\/screeners\"><strong>Univest Screener<\/strong><\/a>.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Key_Catalysts_That_Could_Drive_Tatva_Chintan_Pharma_Share_Price_Higher\"><\/span><strong>Key Catalysts That Could Drive Tatva Chintan Pharma Share Price Higher<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><strong>\u2022 <\/strong>Phase Transfer Catalysts: domestic demand recovering from agrichemical sector rebound<\/p><p><strong>\u2022 <\/strong>Structure Directing Agents for EV battery and clean energy applications \u2014 long-term secular trend<\/p><p><strong>\u2022 <\/strong>Electrolyte salt for lithium-ion batteries: pilot scale production initiated<\/p><p><strong>\u2022 <\/strong>Global specialty chemical companies shifting supply chains away from China<\/p><p><strong>\u2022 <\/strong>New R&amp;D investment in pharmaceutical green chemistry applications<\/p><p>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> for real-time alerts on Tatva Chintan Pharma and daily SEBI-registered research.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Risks_to_Watch_Before_Chasing_the_Rally\"><\/span><strong>Risks to Watch Before Chasing the Rally<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><strong>\u2022 <\/strong>38x P\/E is high on a small and still-developing revenue base<\/p><p><strong>\u2022 <\/strong>Rs 2,680 crore market cap \u2014 small-cap with high liquidity risk<\/p><p><strong>\u2022 <\/strong>Technology specialisation means any product delay or quality issue has outsized impact<\/p><p><strong>\u2022 <\/strong>Agrichemical sector seasonality creates quarterly revenue volatility<\/p><p>Not every surge is sustainable. Investors should carefully evaluate each of these risks relative to their own risk tolerance and investment horizon before making any decision. Consult a SEBI-registered financial advisor.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Technical_Setup_%E2%80%94_Is_the_Rally_Sustainable\"><\/span><strong>Technical Setup \u2014 Is the Rally Sustainable?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Tatva Chintan Pharma is trading at Rs 1,240, which puts the stock +22% above its recent low of Rs 980 and 33% below its 52-week high of Rs 1,850. The stock has reclaimed key moving averages and technical momentum indicators (RSI, MACD) are supportive in the short to medium term. Key resistance is at the 52-week high of Rs 1,850. Short-term support is at Rs 1,200.<\/p><p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Subscribe to Univest Pro for live technical analysis and SEBI-registered F&amp;O setups<\/strong><\/a>.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Institutional_Positioning_and_Market_Sentiment\"><\/span><strong>Institutional Positioning and Market Sentiment<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Tatva Chintan Pharma&#8217;s shareholding reflects: Promoter 47.0%, FII 8.4%, DII 12.6%. FII ownership is moderate, meaning the stock is less sensitive to global risk-off selling than FII-heavy peers. The promoter holding provides management commitment though any reduction in promoter stake would be a key risk to monitor.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Future_Outlook_%E2%80%94_Can_Tatva_Chintan_Pharma_Sustain_the_Rally\"><\/span><strong>Future Outlook \u2014 Can Tatva Chintan Pharma Sustain the Rally?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Tatva Chintan&#8217;s combination of Phase Transfer Catalysts, SDAs, and nascent EV battery chemistry is a genuinely unique specialty chemical proposition. The 12-month target of Rs 1,600\u20131,900 implies 29-53% upside. For investors comfortable with small-cap specialty chemical volatility, this is one of India&#8217;s most interesting niche chemistry plays.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Tatva_Chintan_Pharma_Share_Price_Target_2026\"><\/span><strong>Tatva Chintan Pharma Share Price Target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Subscribe to Univest Pro for Premium Stock Research and Targets<\/strong><\/a>.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Short-Term_Target_3-6_Months\"><\/span><strong>Short-Term Target (3-6 Months)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>In the short term, Tatva Chintan Pharma share price target is Rs 1,200\u20131,380 based on current technical positioning and the immediate momentum from the +22% 1 month surge. Support at Rs 1,200 must hold for the bullish case to remain intact.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"12-Month_Analyst_Consensus_Target\"><\/span><strong>12-Month Analyst Consensus Target<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>The analyst consensus 12-month Tatva Chintan Pharma share price target is Rs 1,600\u20131,900, implying meaningful upside from the current price of Rs 1,240. This target assumes the catalysts identified in this article materialise and the macro environment remains broadly supportive.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Long-Term_Target_FY27-FY28\"><\/span><strong>Long-Term Target (FY27-FY28)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>In a bull scenario where key catalysts deliver, the Tatva Chintan Pharma share price target for FY28 is Rs 2,200\u20132,800. This long-term target represents a scenario where the company executes consistently and the sectoral tailwinds accelerate beyond current consensus expectations.<\/p><p>Track Tatva Chintan Pharma live and compare with sector peers on the <a href=\"https:\/\/univest.in\/screeners\"><strong>Univest Screener<\/strong><\/a>.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Tatva Chintan Pharma&#8217;s +22% surge 1 month is backed by improving fundamentals \u2014 revenue growth of +28% YoY and PAT growth of +55% YoY in the latest quarter. The 12-month analyst consensus target of Rs 1,600\u20131,900 implies significant further upside from the current price of Rs 1,240. The key catalysts and risks outlined in this article are the variables that will determine whether the rally extends or corrects. Investors should evaluate both carefully before making any position decision.<\/p><p>This article is for informational purposes only. Please conduct your own research and consult a SEBI-registered financial advisor before making any investment decisions.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q1_Why_did_Tatva_Chintan_surge_22_in_1_month\"><\/span><strong>Q1. Why did Tatva Chintan surge 22% in 1 month?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Tatva Chintan&#8217;s 22% rally was driven by Q3 FY26 revenue +28% YoY and PAT +55% YoY on rising Phase Transfer Catalyst demand, improved Dahej plant utilisation, and excitement around EV battery chemical potential.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q2_What_is_Tatva_Chintans_share_price_target_2026\"><\/span><strong>Q2. What is Tatva Chintan&#8217;s share price target 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Analyst consensus 12-month target is Rs 1,600\u20131,900. Short-term is Rs 1,200\u20131,380. Long-term bull case is Rs 2,200\u20132,800 for FY28.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q3_What_does_Tatva_Chintan_make\"><\/span><strong>Q3. What does Tatva Chintan make?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Tatva Chintan makes Phase Transfer Catalysts (PTCs), Structure Directing Agents (SDAs), and Electrolyte Salts. PTCs are used in pharmaceutical and agrochemical synthesis; SDAs are used in zeolite synthesis for oil refining; Electrolyte Salts are for batteries.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q4_What_is_a_Phase_Transfer_Catalyst\"><\/span><strong>Q4. What is a Phase Transfer Catalyst?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>A Phase Transfer Catalyst (PTC) enables chemical reactions between substances in different phases (e.g., liquid and solid). PTCs reduce solvent usage, waste generation, and reaction time \u2014 making pharmaceutical and agrochemical synthesis more efficient and environmentally friendly.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q5_What_is_Tatva_Chintans_market_cap\"><\/span><strong>Q5. What is Tatva Chintan&#8217;s market cap?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Tatva Chintan&#8217;s market cap is approximately Rs 2,680 crore \u2014 a small-cap company. The stock is at Rs 1,240 with a 52-week range of Rs 980 to Rs 1,850.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Recent_Article\"><\/span><strong>Recent Article<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/blogs\/tcs-share-price-target\">TCS Share Price Target 2026 \u2014 Key Factors, Financial Performance &amp; Analyst Forecast<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/nestle-india-share-price-target\">Nestle India Share Price Target 2026 \u2014 Key Factors, Financial Performance &amp; Analyst Forecast<\/a><\/p><p><a href=\"http:\/\/univest.in\/blogs\/state-bank-of-india-share-price-target\">State Bank of India Share Price Target 2026: Analyst Forecasts, Bull &amp; Bear Case<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/hindustan-unilever-share-price-target\">Hindustan Unilever Share Price Target 2026 \u2014 Key Factors, Financial Performance &amp; Analyst Forecast<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Tatva Chintan Pharma Chem has surged 22% in one month \u2014 and for investors who bought into the IPO buzz of 2021 and watched the stock collapse 50%+ from its listing price, this recovery is both exciting and overdue. This article covers every key reason behind Tatva Chintan Pharma&#8217;s recent surge, what the data says<\/p>\n","protected":false},"author":27,"featured_media":69564,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802],"class_list":["post-69555","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"metadata":{"_edit_lock":["1775808223:27"],"_last_editor_used_jetpack":["block-editor"],"rank_math_internal_links_processed":["1"],"amazonS3_cache":["a:4:{s:62:\"\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/04\/image-549.jpeg\";a:2:{s:2:\"id\";i:69562;s:11:\"source_type\";s:13:\"media-library\";}s:71:\"\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/04\/image-549-1024x536.jpeg\";a:2:{s:2:\"id\";i:69562;s:11:\"source_type\";s:13:\"media-library\";}s:94:\"\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/10133100\/image-549.jpeg\";a:2:{s:2:\"id\";i:69562;s:11:\"source_type\";s:13:\"media-library\";}s:103:\"\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/10133100\/image-549-1024x536.jpeg\";a:2:{s:2:\"id\";i:69562;s:11:\"source_type\";s:13:\"media-library\";}}"],"rank_math_primary_category":["842"],"rank_math_seo_score":["81"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"rank_math_title":["Tatva Chintan Share Price Target 2026: Up 22% \u2014 Green Chemical Specialty Play Worth Owning?"],"rank_math_description":[" Tatva Chintan up 22% in 1 month. 28% revenue growth, PAT +55%, phase transfer catalysts and EV chemicals. Target 2026: Rs 1,600\u20131,900.\n"],"rank_math_focus_keyword":["Tatva Chintan"],"_thumbnail_id":["69564"],"_edit_last":["27"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["7789"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/10133124\/tatva-chintan-Share-Price-Target-2026.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/69555","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=69555"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/69555\/revisions"}],"predecessor-version":[{"id":69567,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/69555\/revisions\/69567"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/69564"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=69555"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=69555"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=69555"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}